Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - SHORT-TERM DEBT
Short-term Debt ITCI - Intra-Cellular Therapies, Inc.
3.61 M
LAST VALUE
-26.75%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR